Comparison between Mangal Compusolution IPO and Onyx Biotec IPO.
IPO Details
Mangal Compusolution IPO is a SME Bookbuilding IPO proposed to list at BSE SME while Onyx Biotec IPO is a SME Bookbuilding proposed to list at NSE SME.
Issue Size and Price
The total issue size of Mangal Compusolution IPO is up to ₹15.39 Cr whereas the issue size of the Onyx Biotec IPO is up to ₹27.85 Cr. The final issue price of Mangal Compusolution IPO is ₹45.00 per share and of Onyx Biotec IPO is ₹61.00 per share.
IPO Timetable
Mangal Compusolution IPO opens on Nov 12, 2024, while Onyx Biotec IPO opens on Nov 13, 2024. The closing date of Mangal Compusolution IPO and Onyx Biotec IPO is Nov 14, 2024, and Nov 18, 2024, respectively.
| | Mangal Compusolution IPO | Onyx Biotec IPO |
|---|
| Anchor Bid Date | | Nov 12, 2024 |
| Issue Open | Nov 12, 2024 | Nov 13, 2024 |
| Issue Close | Nov 14, 2024 | Nov 18, 2024 |
| Basis Of Allotment (Tentative) | Nov 18, 2024 | Nov 19, 2024 |
| Initiation of Refunds (Tentative) | Nov 19, 2024 | Nov 20, 2024 |
| Credit of Share (Tentative) | Nov 19, 2024 | Nov 20, 2024 |
| Listing date (Tentative) | Nov 21, 2024 | Nov 22, 2024 |
| Anchor Lockin End date 1 | | Dec 19, 2024 |
| Anchor Lockin End date 2 | | Feb 17, 2025 |
Financials & KPIs
Mangal Compusolution IPO P/E ratio is 11.66, as compared to Onyx Biotec IPO P/E ratio of 26.81.
Shares Offered
In the Mangal Compusolution IPO Retail Individual Investors (RII) are offered 17,10,000 shares while in Onyx Biotec IPO retail investors are offered 17,10,000 shares. Qualified Institutional Buyers (QIB) are offered in Mangal Compusolution IPO and 9,12,000 shares in Onyx Biotec IPO.
| | Mangal Compusolution IPO | Onyx Biotec IPO |
|---|
| Anchor Investor Reservation | | 13,66,000 shares |
| Market Maker Reservation | 1,86,000 shares | 2,44,000 shares |
| QIB | | 9,12,000 shares |
| NII | 17,10,000 shares | 6,88,000 shares |
| RII | 17,10,000 shares | 16,00,000 shares |
| Employee | | |
| Others | | |
| Total | 34,20,000 shares | 45,66,000 shares |
Bids Received (Subscription)
Mangal Compusolution IPO subscribed 34.59x in total, whereas Onyx Biotec IPO subscribed 138.77x.
